Correlation Between Icosavax and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Icosavax and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Icosavax and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Icosavax and Transcode Therapeutics, you can compare the effects of market volatilities on Icosavax and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Icosavax with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Icosavax and Transcode Therapeutics.
Diversification Opportunities for Icosavax and Transcode Therapeutics
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Icosavax and Transcode is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Icosavax and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Icosavax is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Icosavax are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Icosavax i.e., Icosavax and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Icosavax and Transcode Therapeutics
Given the investment horizon of 90 days Icosavax is expected to generate 0.36 times more return on investment than Transcode Therapeutics. However, Icosavax is 2.77 times less risky than Transcode Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 850.00 in Icosavax on August 31, 2024 and sell it today you would earn a total of 52.00 from holding Icosavax or generate 6.12% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 28.51% |
| Values | Daily Returns |
Icosavax vs. Transcode Therapeutics
Performance |
| Timeline |
| Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Transcode Therapeutics |
Icosavax and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Icosavax and Transcode Therapeutics
The main advantage of trading using opposite Icosavax and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Icosavax position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.| Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |